The antipsychotic dopamine 2 receptor antagonist diphenylbutylpiperidines improve glycemia in experimental obesity by inhibiting succinyl-CoA:3-ketoacid CoA transferase

Seyed Amirhossein Tabatabaei Dakhili(University of Alberta), John R. Ussher(University of Alberta), Carlos A. Velázquez‐Martínez(University of Alberta), Christina T. Saed(University of Alberta), Peter A. Crawford(University of Minnesota System), Rabih Abou Farraj(University of Alberta), Crystal Lee(Deakin University), Farah Eaton(University of Alberta), J. N. Mark Glover(University of Alberta), Jadin J. Chahade(University of Alberta), Amanda A. Greenwell(University of Alberta), Jordan S. F. Chan(University of Alberta), Rami Al Batran(Université de Montréal), Keshav Gopal(University of Alberta), Kunyan Yang(University of Alberta)
Unknown
October 18, 2022
Cited by 0


Related Papers